İstanbul escort bayan sivas escort samsun escort bayan sakarya escort Muğla escort Mersin escort Escort malatya Escort konya Kocaeli Escort Kayseri Escort izmir escort bayan hatay bayan escort antep Escort bayan eskişehir escort bayan erzurum escort bayan elazığ escort diyarbakır escort escort bayan Çanakkale Bursa Escort bayan Balıkesir escort aydın Escort Antalya Escort ankara bayan escort Adana Escort bayan

60.3 F
San Diego
Wednesday, May 22, 2024
-Advertisement-

Neurelis Inc. Announces Possible Acquisition by Biotie Therapies for $9.75M

San Diego pharmaceutical company Neurelis Inc. announced that it may be acquired by Finnish biotech Biotie Therapies Inc. for $9.75 million.

The agreement includes a development deal for Neurelis’ drug candidate intranasal diazepam, a nasal inhaler that treats seizures. Biotie will also pay $1 million for the exclusive option to acquire all outstanding shares of Neurelis.

If it chooses to acquire Neurelis, it will pay an additional $8.75 million, Biotie said.

During the option period, Biotie said it will conduct a development program for the epilepsy drug. It will work with Neurelis to advance the program with the U.S. Food and Drug Administration to prepare for clinical trials.

Neurelis is a small, privately held pharmaceutical company. Biotie, founded in 1998, has 38 employees. It reported operating income of $33.47 for the 2012 fiscal year.

— Meghana Keshavan

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-